InChiKey: NDVQUNZCNAMROD-RZUBCFFCSA-N
Pimecrolimus blocks T-lymphocyte activation pathway by inhibiting calcineurin function
suppresses the secretion of cholesterol and triacylglycerol and simultaneously reduces apolipoprotein B in HepG2 cells
ITF2357 reduces cytokines and protects islet β cells in vivo and in vitro
It is administered as a topical ophthalmic in the form of a 2% solution
Elacridar Hydrochloride ron InChiKey: NDVQUNZCNAMROD-RZUBCFFCSA-NElacridar, also known as GF120918A, is a P glycoprotein (P gp) inhibitor, and has been used both in vitro and in vivo as a tool inhibitor of P glycoprotein (Pgp) to investigate the role of transporters in the disposition of various test molecules. In vitro, GF120918A demonstrated high plasma protein binding across species, although a definitive protein binding evaluation was precluded by poor recovery, particularly in buffer and in mouse, rat, and dog